Page last updated: 2024-10-30

metformin and Plica Syndrome

metformin has been researched along with Plica Syndrome in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Zheng, M1
Zhu, Y1
Wei, K1
Pu, H1
Peng, R1
Xiao, J1
Liu, C1
Sun, X1
Aung, TKK1
Chuah, TY1
Chua, MWJ1

Other Studies

2 other studies available for metformin and Plica Syndrome

ArticleYear
Metformin Attenuates the Inflammatory Response via the Regulation of Synovial M1 Macrophage in Osteoarthritis.
    International journal of molecular sciences, 2023, Mar-10, Volume: 24, Issue:6

    Topics: Animals; Chondrocytes; Diabetes Mellitus, Type 2; Macrophages; Metformin; Mice; Osteoarthritis; Phos

2023
More Than Meets the Eye: A Patient with Hand Swelling and Newly Diagnosed Diabetes Mellitus.
    The American journal of medicine, 2021, Volume: 134, Issue:11

    Topics: Aged; Amlodipine; Anemia; Antihypertensive Agents; Blood Sedimentation; C-Reactive Protein; Diabetes

2021